AXA PPP reverses decision on Herceptin

AXA PPP has agreed to cover the cost of Herceptin following the National Institute of Clinical Excellence’s decision to approve the drug for use in the early stages of breast cancer.Most of the major insurers, including BUPA, Norwich Union and WPA, have been paying for the drug since last year, but AXA PPP and Legal…